111 related articles for article (PubMed ID: 38128238)
1. Levels of soluble TNF receptors (sTNFR1 and sTNFR2) increase with clinical worsening of patients and are related to COVID-19 mortality.
Aciole MR; Gonçales JP; Neves PAF; Soares CRP; de Oliveira MI; de Melo HRL; de Lima Neto RG; Moura LCRV; Araújo PSR; de Lorena VMB
Immunobiology; 2024 Jan; 229(1):152748. PubMed ID: 38128238
[TBL] [Abstract][Full Text] [Related]
2. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis.
Owczarek D; Cibor D; Głowacki MK; Cieśla A; Mach P
Pol Arch Med Wewn; 2012; 122(12):616-23. PubMed ID: 23160117
[TBL] [Abstract][Full Text] [Related]
3. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis.
Ribeiro CM; Oliveira SR; Alfieri DF; Flauzino T; Kaimen-Maciel DR; Simão ANC; Maes M; Reiche EMV
Inflamm Res; 2019 Dec; 68(12):1049-1059. PubMed ID: 31559449
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
[TBL] [Abstract][Full Text] [Related]
6. Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients.
Mortaz E; Tabarsi P; Jamaati H; Dalil Roofchayee N; Dezfuli NK; Hashemian SM; Moniri A; Marjani M; Malekmohammad M; Mansouri D; Varahram M; Folkerts G; Adcock IM
Front Immunol; 2021; 12():592727. PubMed ID: 33968010
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokine kinetics to single bouts of acute moderate and intense aerobic exercise in women with active and inactive systemic lupus erythematosus.
Perandini LA; Sales-de-Oliveira D; Mello S; Camara NO; Benatti FB; Lima FR; Borba E; Bonfa E; Roschel H; Sá-Pinto AL; Gualano B
Exerc Immunol Rev; 2015; 21():174-85. PubMed ID: 25825870
[TBL] [Abstract][Full Text] [Related]
8. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
[TBL] [Abstract][Full Text] [Related]
9. Significant Induction of Soluble TNFR2 Compared with TNFR1 in Serum Samples of HIV Patients with or without Antiretroviral Medication.
Sarfo B; Haile ZT; Deletsu S; Mensah EA; Bonney EY
Infect Disord Drug Targets; 2020; 20(2):175-181. PubMed ID: 30324895
[TBL] [Abstract][Full Text] [Related]
10. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
[TBL] [Abstract][Full Text] [Related]
11. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.
Gómez-Banoy N; Cuevas V; Higuita A; Aranzález LH; Mockus I
J Diabetes Complications; 2016 Jul; 30(5):852-7. PubMed ID: 27068267
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha and soluble TNF-alpha receptor responses in young vs. middle-aged males following eccentric exercise.
Arroyo E; Wells AJ; Gordon JA; Varanoske AN; Gepner Y; Coker NA; Church DD; Fukuda DH; Stout JR; Hoffman JR
Exp Gerontol; 2017 Dec; 100():28-35. PubMed ID: 29038027
[TBL] [Abstract][Full Text] [Related]
13. Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus.
Santos FM; Telles RW; Lanna CC; Teixeira AL; Miranda AS; Rocha NP; Ribeiro AL
Lupus; 2017 Jan; 26(1):10-16. PubMed ID: 27365371
[TBL] [Abstract][Full Text] [Related]
14. Levels of soluble tumor necrosis factor receptor 1 and 2 are associated with survival after ST segment elevation myocardial infarction.
Befekadu R; Grenegård M; Larsson A; Christensen K; Ramström S
Sci Rep; 2022 Aug; 12(1):14762. PubMed ID: 36042366
[TBL] [Abstract][Full Text] [Related]
15. Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease.
Moreira JM; da Silva AN; Marciano Vieira ÉL; Teixeira AL; Kummer AM; Simões E Silva AC
Pediatr Nephrol; 2019 Feb; 34(2):349-352. PubMed ID: 30374604
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study.
Morange PE; Tregouet DA; Godefroy T; Saut N; Bickel C; Rupprecht HJ; Lackner K; Barbaux S; Poirier O; Peiretti F; Nalbone G; Juhan-Vague I; Blankenberg S; Tiret L
J Mol Med (Berl); 2008 Oct; 86(10):1153-61. PubMed ID: 18600307
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus.
Ferreira GA; Teixeira AL; Calderaro DC; Sato EI
Clin Exp Rheumatol; 2016; 34(1):42-8. PubMed ID: 26574625
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia.
Noto C; Gadelha A; Belangero SI; Spindola LM; Rocha NP; de Miranda AS; Teixeira AL; Cardoso Smith MA; de Jesus Mari J; Bressan RA; Brietzke E
J Psychiatr Res; 2013 Apr; 47(4):467-71. PubMed ID: 23360651
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure.
Denollet J; Schiffer AA; Kwaijtaal M; Hooijkaas H; Hendriks EH; Widdershoven JW; Kupper N
Am J Cardiol; 2009 Feb; 103(3):399-404. PubMed ID: 19166697
[TBL] [Abstract][Full Text] [Related]
20. Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis.
Bessa TF; Cordeiro CA; Gonçalves RM; Young LH; Campos WR; Oréfice F; Teixeira AL
Braz J Infect Dis; 2012; 16(6):540-4. PubMed ID: 23141990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
